Relmada Therapeutics (RLMD) HAP Data Significantly Improves Commercial Outlook - Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. CRWV
8. CME
9. ADBE
10. HUMA

Go back to Relmada Therapeutics (RLMD) HAP Data Significantly Improves Commercial Outlook - Analyst
(NASDAQ: RLMD) Delayed: 6.52 +0.14 (2.19%)
Previous Close $6.38    52 Week High $4.10 
Open $6.43    52 Week Low $0.87 
Day High $6.62    P/E N/A 
Day Low $6.36    EPS $0.00 
Volume 865,360